This inventor holds 2 USPTO granted patents. Top assignees: Incyte Corporation, Incyte Genomics, Inc.. Active years: 2003-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2004
Title: Debora W Tingley: Innovator in Genetic Research
Introduction
Debora W Tingley is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of genetic research, particularly in understanding brain disorders. With a total of 2 patents, her work has implications for diagnosing and treating conditions such as Alzheimer's disease.
Latest Patents
Tingley's latest patents include groundbreaking inventions. The first patent focuses on "Genes expressed in Alzheimer's disease," which relates to a composition comprising a plurality of cDNAs that are differentially expressed in brain disorders. This invention may be utilized for diagnosing, staging, treating, or monitoring subjects with brain disorders. The second patent, titled "Down syndrome critical region 1-like proteins," provides a mammalian nucleic acid molecule and its fragments. This invention also includes the use of the nucleic acid molecule for characterizing, diagnosing, evaluating, and treating conditions associated with gene expression.
Career Highlights
Throughout her career, Tingley has worked with notable companies such as Incyte Corporation and Incyte Genomics, Inc. Her experience in these organizations has allowed her to advance her research and contribute to significant scientific advancements.
Collaborations
Some of her notable coworkers include Jeanne F Loring and Carla M Edwards. Their collaborative efforts have further enriched the research landscape in which Tingley operates.
Conclusion
Debora W Tingley is a distinguished inventor whose work in genetic research has the potential to transform the understanding and treatment of brain disorders. Her patents reflect her commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

